formsc13da.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 5)*
Metropolitan Health Networks
(Name of Issuer)
Common Stock, $0.001 par value
(Title of Class of Securities)
592142103
Cusip Number
Norman H. Pessin
366 Madison Avenue, 14th Floor
New York, NY 10017
212-661-2670
CC:
Steven Wolosky, Esq.
Olshan, Grundman, Frome, Rosenzweig, & Wolosky, LLP
Park Avenue Tower
65 East 55th Street
New York, NY 10022
212-451-2300
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
January 25, 2012
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement of Schedule 13G to report the acquisition which is the subject of the Schedule 13D, and is filing this schedule because of ss. 240.13d-1(e), ss. 240.13d-1(f) or ss. 240.13d-1(g), check the following box o.
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss.240.13d-7(b) for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
PAGE 2
CUSIP No. 592142103
Schedule 13D
| 1 |
NAME OF REPORTING PERSON
|
| |
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
| |
|
| |
SEP IRA FBO Norman H. Pessin ###-##-####
|
| |
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
| |
(a) R
|
| |
|
|
3
|
SEC USE ONLY
|
| |
|
|
4
|
SOURCE OF FUNDS
|
| |
PF
|
| |
|
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
| |
o
|
| |
|
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
| |
United States
|
|
NUMBER OF
SHARES
BENEFICALLY
OWNED
BY EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
|
| |
1,153,529
|
| |
|
|
8
|
SHARED VOTING POWER
|
| |
|
|
9
|
SOLE DISPOSITIVE POWER
|
| |
1,153,529
|
| |
|
|
| |
10 |
SHARED DISPOSITIVE POWER |
| |
|
|
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
| |
1,153,529
|
| |
|
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
|
| |
o
|
| |
|
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
| |
1) 2.6%
|
| |
|
|
14
|
TYPE OF REPORTING PERSON*
|
| |
IN
|
PAGE 3
CUSIP No. 592142103
Schedule 13D
| 1 |
NAME OF REPORTING PERSON
|
| |
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
| |
|
| |
Sandra F. Pessin 085-32-51752
|
| |
|
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
| |
(a) R
|
| |
|
|
3
|
SEC USE ONLY
|
| |
|
|
4
|
SOURCE OF FUNDS
|
| |
PF
|
| |
|
|
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
| |
o
|
| |
|
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
| |
United States
|
|
NUMBER OF
SHARES
BENEFICALLY
OWNED
BY EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
|
| |
792,308
|
| |
|
|
8
|
SHARED VOTING POWER
|
| |
|
|
9
|
SOLE DISPOSITIVE POWER
|
| |
792,308
|
| |
|
| |
10 |
SHARED DISPOSITIVE POWER |
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
| |
792,308
|
| |
|
|
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
|
| |
o
|
| |
|
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
| |
1.8%
|
| |
|
|
14
|
TYPE OF REPORTING PERSON*
|
| |
IN
|
PAGE 4
CUSIP No. 592142103
Schedule 13D
|
Item 1.
|
Security and Issuer
|
This Schedule 13D relates to the common stock, $0.001 par value (the "Common Stock"), of Metropolitan Health Networks, Inc. (the "Issuer"), whose principal executive offices are located at 250 Australia Avenue South, Suite 400, West Palm Beach, Florida 33401
|
Item 2.
|
Identity and Background
|
This Schedule 13D is being filed by and for Norman H. Pessin and Sandra F. Pessin (each a “Reporting Person”)Certain information with respect to each Reporting Person is set forth below:
| |
Name and Address:
|
1) Norman H. Pessin
|
| |
|
366 Madison Avenue, 14th Floor
|
| |
|
New York, NY 10017
|
| |
|
|
| |
|
2) Sandra F. Pessin
|
| |
|
366 Madison Avenue, 14th Floor
|
| |
|
New York, NY 10017
|
| |
|
|
| |
Principal Occupation:
|
1) Retired |
| |
|
|
| |
|
2) Housewife
|
| |
|
|
| |
Criminal convictions:
|
1) None
|
| |
|
|
| |
|
2) None
|
| |
|
|
| |
Civil proceedings:
|
1) None
|
| |
|
|
| |
|
2) None
|
| |
|
|
| |
Citizenship:
|
1) United States
|
| |
|
|
| |
|
2) United States
|
Item 3.
The aggregate purchase price of the 1,153,529 shares of common stock owned by Norman H. Pessin is approximately $780,959, including brokerage commissions. The shares of common stock owned by Norman H. Pessin were acquired with personal funds. The aggregate purchase price of the 792,308 shares of common stock owned by Sandra F. Pessin is approximately $605,623, including brokerage commissions. The shares of common stock owned by Sandra F. Pessin were acquired with personal funds.
PAGE 5
CUSIP No. 592142103
Schedule 13D
|
Item 4.
|
Purposes of the Transactions
|
The Reporting Person originally purchased the Shares based on the belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable.
The Reporting Person intends to review their investment in the Issuer on a continuing basis. Depending on various factors including, without limitation, the Issuer’s financial position and investment strategy, the price levels of the Shares, conditions in the securities markets and general economic and industry conditions, the Reporting Person may in the future take such actions with respect to its investment in the Issuer as they deem appropriate including, without limitation, communications with management and the Board of Directors of the Issuer, engaging in discussions with third parties about the Issuer, making proposals to the Issuer concerning changes to the capitalization or operations of the Issuer, purchasing additional Shares, selling some or all of their Shares, engaging in short selling of or any hedging or similar transaction with respect to the Shares, or changing their intention with respect to any and all matters referred to in Item 4.
|
Item 5.
|
Interest in Securities of the Issuer
|
Norman H. Pessin owns 1,153,529 shares of common stock of the issuer, constituting 2.6% of the outstanding shares thereof. Sandra F. Pessin owns 792,308 shares of common stock of the issuer, constituting 1.8% of the outstanding shares thereof.
PAGE 6
CUSIP No. 592142103
Schedule 13D
|
Item 6.
|
Contracts, Arrangements, Understandings or Relationships with respect to Securities of the Issuer
|
None.
|
Item 7.
|
Material to Be Filed as Exhibits
|
None.
Signatures
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
/s/ Norman H. Pessin |
|
| |
Norman H. Pessin
|
|
| |
|
|
| |
/s/ Sandra F. Pessin
|
|
| |
Sandra F. Pessin
|
|
| |
|
|
| January 25, 2012 |
|
|